# Phoska Biopharma Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/phoska-biopharma-pte

- Industry: Biotechnology
- Headquarters: Singapore, Singapore
- Total disclosed funding: $2.2M
- Latest round: Seed (Mar 31, 2023)
- Investors on record: 2

## About

Based in Singapore, and founded in 2019, Phoska Biopharma Pte. Ltd. operates as a pre-clinical stage company that focuses on developing new therapies. In August 2022, Phoska Biopharma Pte. Ltd. raised USD 1 million in venture funding from Albrekca and Sprim Ventures. As of August 2022, the company is led by its CEO Mark Hasleton.

Phoska Biopharma Pte. Ltd. is engaged in developing therapies to treat liver and metabolic conditions such as fatty liver and cardiovascular health

## Funding rounds

- Seed, Mar 31, 2023, $2.2M — Albrekca, Sprim Ventures

## Investors

- Albrekca — Seed
- Sprim Ventures (https://capitalatlas.ai/funds/sprim-ventures) — Seed